MediWound (MDWD) FCF Margin (2014 - 2025)
MediWound (MDWD) recorded quarterly FCF Margin of 619.93% in Q4 2025, down 1433.99% quarter-over-quarter from 40.41% in Q3 2025, and down 39087.0% on a YoY basis from N/an in Q4 2024.
MediWound (MDWD) FCF Margin (2014 - 2025) Analysis & Trends
MediWound's FCF Margin history runs 12 years deep, the most recent figure standing at 619.93% for Q4 2025.
- In Q4 2025, FCF Margin fell 39087.0% year-over-year to 619.93%; the TTM figure through Dec 2025 stood at 142.98% (down 3637.0% YoY), while the FY2025 annual figure was 127.52%, down 2913.0% from the prior year.
- FCF Margin was 619.93% for Q4 2025 at MediWound, down from 40.41% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 56.78% in Q1 2023 to a low of 619.93% in Q4 2025.
- Historically, FCF Margin has averaged 110.65% across 5 years, with a median of 78.46% in 2022.
- The sharpest annual moves came in 2023 and 2025: FCF Margin surged 14539 bps in 2023, then plunged 39087 bps in 2025.
- A 5-year view of FCF Margin shows it stood at 38.62% in 2021, then soared by 96 bps to 1.6% in 2022, then tumbled by 15503 bps to 249.79% in 2023, then gained by 8 bps to 229.06% in 2024, then plunged by 171 bps to 619.93% in 2025.
- The last three FCF Margin figures came in at 619.93% (Q4 2025), 40.41% (Q3 2025), and 121.5% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -3.98% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 43.35% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -619.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -619.93% |
| Sep 30, 2025 | -40.41% |
| Jun 30, 2025 | -121.50% |
| Mar 31, 2025 | -79.67% |
| Dec 31, 2024 | -229.06% |
| Sep 30, 2024 | -58.87% |
| Jun 30, 2024 | -17.32% |
| Mar 31, 2024 | -67.47% |
| Dec 31, 2023 | -249.79% |
| Sep 30, 2023 | -32.79% |
| Jun 30, 2023 | -118.45% |
| Mar 31, 2023 | 56.78% |
| Dec 31, 2022 | -1.60% |
| Sep 30, 2022 | -77.25% |
| Jun 30, 2022 | -184.23% |
| Mar 31, 2022 | -88.61% |
| Dec 31, 2021 | -38.62% |
| Sep 30, 2021 | -81.56% |
| Jun 30, 2021 | -31.72% |
| Mar 31, 2021 | -130.85% |